Abstract
The syntheses and SAR investigations of novel CB 1 receptor antagonists based on a 1,2-diaryl piperidine core have been described. Optimization of this core afforded a compound with robust in vivo potency by reducing food intake in a mouse DIO model.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have